Featured articles from the journal CHEST®, May 2023

Published monthly, the journal CHESTopens in new tab/window^® features peer-reviewed, cutting-edge original research in chest medicine: Pulmonary, critical care and sleep medicine and related disciplines. Journal topics include asthma, chest infections, COPD, critical care, diffuse lung disease, education and clinical practice, pulmonary vascular disease, sleep, thoracic oncology and the humanities.

The May issueopens in new tab/window of the CHEST journal contains 50 articles, including clinically relevant research, reviews, case series, commentary and more. Each month, the journal also offers complementary web and multimedia resourcesopens in new tab/window, including visual abstracts, to expand the reach of its most interesting, timely and relevant research.

“To raise awareness for cystic fibrosis in May, in addition to the research included in the latest issue, I recommend visiting the journal’s Adult Cystic Fibrosis Seriesopens in new tab/window,” says Editor in Chief of the journal, Peter Mazzone, MD, MPH, FCCP. “One of the four available journal CHESTSpecial Seriesopens in new tab/window, the grouping around adult cystic fibrosis examines a once fatal childhood condition (>90% mortality rate in the first year of life) that is now a disease across the age spectrum, including adulthood.”

Also included in the current issue of the journal CHEST:

• ●

  Asthma

“A Total Diet Replacement Weight Management Program for Difficult-to-Treat Asthma Associated With Obesityopens in new tab/window” shows that over 16 weeks, the Counterweight-Plus Program resulted in clinically relevant improvements in both asthma control and quality-of-life indexes, with substantial weight loss, as compared with usual care. View the visual abstract for this researchopens in new tab/window.

• ●

  Critical Care

Looking at targeted temperature management in the ICU, “Differential Effect of Targeted Temperature Management Between 32 °C and 36 °C Following Cardiac Arrest According to Initial Severity of Illnessopens in new tab/window” finds 32 °C to 36 °C was significantly associated with better outcomes in patients with low and high severity Cardiac Arrest Hospital Prognosis score at ICU admission. View the visual abstract for this researchopens in new tab/window.

• ●

  Education and Clinical Practice

A pilot randomized, controlled trial, “Nebulized vs IV Tranexamic Acid for Hemoptysisopens in new tab/window,” suggests nebulized tranexamic acid may be more efficacious than IV tranexamic acid in reducing the amount of hemoptysis and the need for interventional procedures in the ED. View the visual abstract for this researchopens in new tab/window. Listen to a podcast of the experts discussing their findings.opens in new tab/window

• ●

  Thoracic Oncology

Assessing the relationship between pulmonary nodules (PNs) and lung cancer in the Medicare population, “Pulmonary Nodules, Lung Cancer Screening, and Lung Cancer in the Medicare Populationopens in new tab/window” suggests PNs represent a relatively common presentation of potentially curable lung cancer. Listen to a podcast of the experts discussing their findings.opens in new tab/window

---

Notes for editors

To view the entire May issue of CHEST journal (volume 163, issue 5), published by Elsevier, visit journal.chestnet.orgopens in new tab/window and follow @journal_CHESTopens in new tab/window on Twitter for the latest journal news.

Full text of these articles and interviews with the authors are available to credentialed journalists upon request; contact Laura DiMasi, Senior Specialist, Communications and Public Relations, American College of Chest Physicians (CHEST), at [email protected]opens in new tab/window.

About the journal CHEST^®

The journal CHESTopens in new tab/window, the official publication of the American College of Chest Physicians®, features the best in peer-reviewed, cutting-edge original research in the multidisciplinary specialties of chest medicine: pulmonary, critical care, and sleep medicine; thoracic surgery; cardiorespiratory interactions; and related disciplines. Published since 1935, it is home to the highly regarded clinical practice guidelines and consensus statements. Access the journal CHEST online at journal.chestnet.orgopens in new tab/window.

About the American College of Chest Physicians

The American College of Chest Physicians^® (CHEST) is the global leader in the prevention, diagnosis, and treatment of chest diseases. Its mission is to champion advanced clinical practice, education, communication, and research in chest medicine. It serves as an essential connection to clinical knowledge and resources for its 19,000+ members from around the world who provide patient care in pulmonary, critical care, and sleep medicine. For information about the American College of Chest Physicians, and its flagship journal CHEST^®, visit chestnet.org.opens in new tab/window

About Elsevier

As a global leader in scientific information and analytics, Elsevier helps researchers and healthcare professionals advance science and improve health outcomes for the benefit of society. We do this by facilitating insights and critical decision-making with innovative solutions based on trusted, evidence-based content and advanced AI-enabled digital technologies.

We have supported the work of our research and healthcare communities for more than 140 years. Our 9,500 employees around the world, including 2,500 technologists, are dedicated to supporting researchers, librarians, academic leaders, funders, governments, R&D-intensive companies, doctors, nurses, future healthcare professionals and educators in their critical work. Our 2,900 scientific journals and iconic reference books include the foremost titles in their fields, including Cell Press, The Lancet and Gray’s Anatomy.

Together with the Elsevier Foundationopens in new tab/window, we work in partnership with the communities we serve to advance inclusion and diversity in science, research and healthcare in developing countries and around the world.

Elsevier is part of RELXopens in new tab/window, a global provider of information-based analytics and decision tools for professional and business customers. For more information on our work, digital solutions and content, visit www.elsevier.com.